Chinese companies supplying ingredients for weight loss drugs, Reuters reports

Some Chinese companies looking to make generic versions of Novo Nordisk’s (NVO) Wegovy also supplied ingredients for more than a billion makeshift doses of weight loss drugs sold online in the U.S. over the past two years, Reuters’ Patrick Wingrove reports. Cheap copies of Wegovy and Eli Lilly’s (LLY) Zepbound are on the retreat in the U.S. as regulators restrict their sale, slowing shipments from Chinese suppliers of the raw ingredients that allowed for growth of the medicines. At least eight Chinese companies, including Jiangsu Sinopep-Allsino Biopharmaceutical and Hybio Pharmaceutical helped flood the U.S. with raw semaglutide and tirzepatide, the main ingredients in Wegovy and Zepbound, respectively, sources tell Reuters.